At present, the impairment of linear growth remains one of the major obstacles to successful social adaptation of children and adolescents with chronic renal insufficiency (CRI), being the recombinant human growth hormone (rhGH) a therapeutic option. We evaluated growth and body composition (BC) in 11 prepubertal patients (9M/2F; 3.5-12.8y) with CRI and short stature and/or slow growth velocity treated with rhGh (0.7-1.0IU/Kg/week) for 18 months. Anthropometry and BC, examined by a tetrapolar bioeletrical impedance, were evaluated before, 6, 12 and […]